Impact of GPCR Structures on Drug Discovery
- PMID: 32243800
- DOI: 10.1016/j.cell.2020.03.003
Impact of GPCR Structures on Drug Discovery
Abstract
Structures of 70 unique G protein-coupled receptors (GPCRs) have been determined, with over 370 structures in total bound to different ligands and the receptors in various conformational states. Structure-based drug design has been applied to an increasing number of GPCR targets over the past decade and now a few of these drug candidates have entered clinical trials. Given the length of time required for a drug to reach the market, there are no documented examples of licensed drugs being developed with the aid of a structure, but this is likely to change as current efforts come to fruition.
Copyright © 2020. Published by Elsevier Inc.
Conflict of interest statement
Declarations of Interest C.G.T. is a founder of Heptares Therapeutics and is a shareholder, scientific advisory board member, and consultant for Sosei Heptares. M.C., N.A.S., and C.d.G. are employees of Heptares Therapeutics and are shareholders of Sosei Heptares.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous